Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catharina Busch

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
Scientific Reports|February 27, 2021
GRAding of functional and anatomical response to DExamethasone implant in patients with Diabetic Macular Edema: GRADE-DME StudyPatricio J Rodríguez-Valdés, Matus Rehak, Dinah Zur, et al.
The British Journal of Ophthalmology|May 2, 2019
Safety of 6000 intravitreal dexamethasone implantsBindu Rajesh, Javier Zarranz-Ventura, Adrian T Fung, et al.
Eye (London, England)|January 19, 2022
Vitrectomized vs non-vitrectomized eyes in DEX implant treatment for DMO-Is there any difference? the VITDEX studyMatias Iglicki, Catharina Busch, Paolo Lanzetta, et al.
Eye (London, England)|October 15, 2020
Subclinical subretinal fluid detectable only by optical coherence tomography in choroidal naevi-the SON studyAdrian T Fung, Raymond Guan, Veronica Forlani, et al.
Ophthalmologica. Journal International D'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde|March 20, 2019
Causative Pathogens of Endophthalmitis after Intravitreal Anti-VEGF Injection: An International Multicenter StudyCatharina Busch, Matias Iglicki, Mali Okada, et al.
Acta Ophthalmologica|March 3, 2020
Baseline predictors for visual acuity loss during observation in diabetic macular oedema with good baseline visual acuityCatharina Busch, Mali Okada, Dinah Zur, et al.
Acta Diabetologica|May 7, 2018
Shall we stay, or shall we switch? Continued anti-VEGF therapy versus early switch to dexamethasone implant in refractory diabetic macular edemaCatharina Busch, Dinah Zur, Samantha Fraser-Bell, et al.
Acta Diabetologica|March 24, 2019
Real-world outcomes of observation and treatment in diabetic macular edema with very good visual acuity: the OBTAIN studyCatharina Busch, Samantha Fraser-Bell, Dinah Zur, et al.
The British Journal of Ophthalmology|June 13, 2018
Long-term visual outcome and its predictors in macular oedema secondary to retinal vein occlusion treated with dexamethasone implantCatharina Busch, Matus Rehak, Chintan Sarvariya, et al.
Acta Diabetologica|September 22, 2019
Real-world outcomes of non-responding diabetic macular edema treated with continued anti-VEGF therapy versus early switch to dexamethasone implant: 2-year resultsCatharina Busch, Samantha Fraser-Bell, Matias Iglicki, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Scientific Reports|February 27, 2021
GRAding of functional and anatomical response to DExamethasone implant in patients with Diabetic Macular Edema: GRADE-DME StudyPatricio J Rodríguez-Valdés, Matus Rehak, Dinah Zur, et al.
The British Journal of Ophthalmology|May 2, 2019
Safety of 6000 intravitreal dexamethasone implantsBindu Rajesh, Javier Zarranz-Ventura, Adrian T Fung, et al.
Eye (London, England)|January 19, 2022
Vitrectomized vs non-vitrectomized eyes in DEX implant treatment for DMO-Is there any difference? the VITDEX studyMatias Iglicki, Catharina Busch, Paolo Lanzetta, et al.
Eye (London, England)|October 15, 2020
Subclinical subretinal fluid detectable only by optical coherence tomography in choroidal naevi-the SON studyAdrian T Fung, Raymond Guan, Veronica Forlani, et al.
Ophthalmologica. Journal International D'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde|March 20, 2019
Causative Pathogens of Endophthalmitis after Intravitreal Anti-VEGF Injection: An International Multicenter StudyCatharina Busch, Matias Iglicki, Mali Okada, et al.
Acta Ophthalmologica|March 3, 2020
Baseline predictors for visual acuity loss during observation in diabetic macular oedema with good baseline visual acuityCatharina Busch, Mali Okada, Dinah Zur, et al.
Acta Diabetologica|May 7, 2018
Shall we stay, or shall we switch? Continued anti-VEGF therapy versus early switch to dexamethasone implant in refractory diabetic macular edemaCatharina Busch, Dinah Zur, Samantha Fraser-Bell, et al.
Acta Diabetologica|March 24, 2019
Real-world outcomes of observation and treatment in diabetic macular edema with very good visual acuity: the OBTAIN studyCatharina Busch, Samantha Fraser-Bell, Dinah Zur, et al.
The British Journal of Ophthalmology|June 13, 2018
Long-term visual outcome and its predictors in macular oedema secondary to retinal vein occlusion treated with dexamethasone implantCatharina Busch, Matus Rehak, Chintan Sarvariya, et al.
Acta Diabetologica|September 22, 2019
Real-world outcomes of non-responding diabetic macular edema treated with continued anti-VEGF therapy versus early switch to dexamethasone implant: 2-year resultsCatharina Busch, Samantha Fraser-Bell, Matias Iglicki, et al.
Pageof 6